{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:27:42Z","timestamp":1780824462526,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1111-9","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T01:24:07Z","timestamp":1442539447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses"],"prefix":"10.1186","volume":"15","author":[{"given":"Maren","family":"Eggers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eickmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"1111_CR1","unstructured":"World Health Organization. Ebola virus disease. www.who.int\/mediacentre\/factsheets\/fs103\/en (2015). Accessed 30 July 2015."},{"key":"1111_CR2","unstructured":"World Health Organization. Frequently asked questions on Ebola virus disease. www.who.int\/csr\/disease\/ebola\/faq-ebola\/en (2015). Accessed 30 July 2015."},{"key":"1111_CR3","unstructured":"World Health Organization. Ebola vaccines, therapies, and diagnostics. Questions and Answers. http:\/\/www.who.int\/medicines\/emp_ebola_q_as\/en\/ (2015). Accessed 30 Jul 2015."},{"key":"1111_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/516015a","volume":"516","author":"E Callaway","year":"2014","unstructured":"Callaway E. Positive results spur race for Ebola vaccine. Nature. 2014;516:15\u20136.","journal-title":"Nature"},{"key":"1111_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1126\/science.347.6219.219","volume":"347","author":"M Enserink","year":"2015","unstructured":"Enserink M. The Ebola Epidemic. High hopes for Guinean vaccine trial. Science. 2015;347:219\u201320.","journal-title":"Science"},{"key":"1111_CR6","unstructured":"World Health Organization. Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola. http:\/\/www.who.int\/csr\/resources\/who-ipc-guidance-ebolafinal-09082014.pdf (2014). Accessed 30 Jul 2015."},{"key":"1111_CR7","unstructured":"EN14476:2013\/FprA1:2015. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of virucidal activity in the medical area. Test method and requirements (Phase 2\/Step 1). 2015."},{"key":"1111_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00103-015-2131-8","volume":"58","author":"HF Rabenau","year":"2015","unstructured":"Rabenau HF, Schwebke I, Bl\u00fcmel J, Eggers M, Glebe D, Rapp I, et al. Leitlinie der Deutschen Vereinigung zur Bek\u00e4mpfung der Viruskrankheiten (DVV) e.V. und des Robert Koch-Instituts (RKI) zur Pr\u00fcfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin [article in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58:493\u2013504.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1111_CR9","doi-asserted-by":"crossref","unstructured":"Rabenau HF, Rapp I, Steinmann J. Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants? BMC Infect Dis. 2010;185.","DOI":"10.1186\/1471-2334-10-185"},{"key":"1111_CR10","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","volume":"19","author":"KJ Stittelaar","year":"2001","unstructured":"Stittelaar KJ, Kuiken T, de Swart RL, van Amerongen G, Vos HW, Niesters HG, et al. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine. 2001;19:3700\u20139.","journal-title":"Vaccine"},{"key":"1111_CR11","volume-title":"Biosafety in Microbiological and Biomedical Laboratories (4th ed)","year":"1999","unstructured":"Richmond JY, McKinney RW, editors. Biosafety in Microbiological and Biomedical Laboratories (4th ed). Washington: CDC-NIH; 1999."},{"key":"1111_CR12","first-page":"729","volume":"46","author":"JD Sparkes","year":"1972","unstructured":"Sparkes JD, Fenje P. The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures. Bull World Health Organ. 1972;46:729\u201334.","journal-title":"Bull World Health Organ"},{"key":"1111_CR13","volume-title":"Topische Infektionstherapie und Prophylaxe. Aktueller Stellenwert von PVP-Jod","year":"1996","unstructured":"Hierholzer G, Reimer K, Weissenbacher ER, editors. Topische Infektionstherapie und Prophylaxe. Aktueller Stellenwert von PVP-Jod. Stuttgart: Thieme; 1996."},{"issue":"Suppl 2","key":"1111_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000246022","volume":"195","author":"W Fleischer","year":"1997","unstructured":"Fleischer W, Reimer K. Povidone Iodine in Antisepsis \u2013 State of the Art. Dermatology. 1997;195 Suppl 2:3\u20139.","journal-title":"Dermatology"},{"issue":"Suppl 2","key":"1111_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000246043","volume":"195","author":"H Schreier","year":"1997","unstructured":"Schreier H, Erdos G, Reimer K, Koenig B, Koenig W, Fleischer W. Molecular effects of povidone-iodine on relevant microorganisms: an electron microscopic and biochemical study. Dermatology. 1997;195 Suppl 2:111\u20136.","journal-title":"Dermatology"},{"key":"1111_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0195-6701(98)90077-9","volume":"38","author":"A Wood","year":"1998","unstructured":"Wood A, Payne D. The action of three antiseptics\/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect. 1998;38:283\u201395.","journal-title":"J Hosp Infect"},{"issue":"Suppl 2","key":"1111_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000246027","volume":"195","author":"R Kawana","year":"1997","unstructured":"Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195 Suppl 2:29\u201335.","journal-title":"Dermatology"},{"key":"1111_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0166-3542(01)00213-3","volume":"54","author":"P Wutzler","year":"2002","unstructured":"Wutzler P, Sauerbrei A, Kl\u00f6cking R, Br\u00f6gmann B, Reimer K. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res. 2002;54:89\u201397.","journal-title":"Antiviral Res"},{"key":"1111_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jhin.2004.01.029","volume":"57","author":"A Sauerbrei","year":"2004","unstructured":"Sauerbrei A, Sehr K, Eichhorn U, Reimer K, Wutzler P. Inactivation of human adenovirus genome by different groups of disinfectants. J Hosp Infect. 2004;57:67\u201372.","journal-title":"J Hosp Infect"},{"key":"1111_CR20","first-page":"105","volume":"52","author":"H Kariwa","year":"2004","unstructured":"Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. Jpn J Vet Res. 2004;52:105\u201312.","journal-title":"Jpn J Vet Res"},{"issue":"Suppl 1","key":"1111_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000089210","volume":"212","author":"H Ito","year":"2006","unstructured":"Ito H, Ito T, Hikida M, Yashiro J, Otsuka A, Kida H, et al. Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products. Dermatology. 2006;212 Suppl 1:115\u20138.","journal-title":"Dermatology"},{"key":"1111_CR22","first-page":"508","volume":"57","author":"H Ito","year":"2009","unstructured":"Ito H, Hikida M, Yashiro J, Kida H, Ito T. Virucidal efficacy of povidone-iodine products against swine influenza viruses. Japanese Journal of Chemotherapy [article in Japanese]. 2009;57:508\u201310.","journal-title":"Japanese Journal of Chemotherapy [article in Japanese]"},{"key":"1111_CR23","first-page":"158","volume":"51","author":"A Sauerbrei","year":"2010","unstructured":"Sauerbrei A, Wutzler P. Virucidal efficacy of povidone-iodine-containing disinfectants. Lett Appl Microbiol. 2010;51:158\u201363.","journal-title":"Lett Appl Microbiol"},{"key":"1111_CR24","first-page":"227","volume":"2","author":"C Spearman","year":"1908","unstructured":"Spearman C. The method of \u2018right and wrong cases\u2019 (\u2018constant stimuli\u2019) without Gauss\u2019s formulae. Br J Psychol. 1908;2:227\u201342.","journal-title":"Br J Psychol"},{"key":"1111_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber G. Beitrag zur Kollektiven Behandlung Pharmakologischer Reihenversuche [article in German]. Arch Exp Path Pharma. 1931;162:480\u20137.","journal-title":"Arch Exp Path Pharma"},{"key":"1111_CR26","volume-title":"Appendix 3: Statistical considerations for assessing virus assays","author":"ICH Q5A","year":"1999","unstructured":"ICH Q5A. Appendix 3: Statistical considerations for assessing virus assays. 1999."},{"key":"1111_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhin.2012.08.005","volume":"82","author":"J Steinmann","year":"2012","unstructured":"Steinmann J, Paulmann D, Becker B, Bischoff B, Steinmann E, Steinmann J. Comparison of virucidal activity of alcohol-based hand sanitizers versus antimicrobial hand soaps in vitro and in vivo. J Hosp Infect. 2012;82:277\u201380.","journal-title":"J Hosp Infect"},{"key":"1111_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1742-481X.2007.00405.x","volume":"5","author":"P Durani","year":"2008","unstructured":"Durani P, Leaper D. Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J. 2008;5:376\u201387.","journal-title":"Int Wound J"},{"key":"1111_CR29","first-page":"160","volume":"18","author":"MM Jackson","year":"2005","unstructured":"Jackson MM. Topical antiseptics in healthcare. Clin Lab Sci. 2005;18:160\u20139.","journal-title":"Clin Lab Sci"},{"key":"1111_CR30","unstructured":"EN1500:2013 Chemical disinfectants and antiseptics. Hygienic handrub. Test method and requirements (Phase 2\/Step 2). 2013."},{"key":"1111_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0166-3542(83)90012-8","volume":"3","author":"W Schurmann","year":"1983","unstructured":"Schurmann W, Eggers HJ. Antiviral activity of an alcoholic hand disinfectant: comparison of the in vitro suspension test with in vivo experiments on hands, and on individual fingertips. Antiviral Res. 1983;3:25\u201341.","journal-title":"Antiviral Res"},{"key":"1111_CR32","unstructured":"Cambridge University Hospitals NHS Foundation Trust. Hand hygiene policy 1a. Version 13. http:\/\/www.cuh.org.uk\/sites\/default\/files\/publications\/Hand%20hygiene%20policy%20%28IC1a%29%20version13%20January%202014.pdf . Accessed 30 Jul 2015."},{"key":"1111_CR33","unstructured":"Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust. Hand Hygiene Procedure. Version 2. http:\/\/www.bfwh.nhs.uk\/about\/foi\/part_two\/cat8\/documents\/ic_docs\/Corp_Proc_418.pdf (2008). Accessed 30 Jul 2015."},{"key":"1111_CR34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s13312-013-0261-3","volume":"50","author":"VS Sharma","year":"2013","unstructured":"Sharma VS, Dutta S, Taneja N, Narang A. Comparing hand hygiene measures in a neonatal ICU: a randomized crossover trial. Indian Pediatr. 2013;50:917\u201321.","journal-title":"Indian Pediatr"},{"key":"1111_CR35","unstructured":"Australian Government Department of Health and Ageing. Laboratory procedures and precautions for samples collected from patients with suspected viral haemorrhagic fevers: guidelines for laboratories that are not associated with a designated isolation hospital. http:\/\/www.commcarelink.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-pubs-other-vhf.htm (2014). Accessed 30 Jul 2015."},{"issue":"Suppl 1","key":"1111_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000310889","volume":"211","author":"A Kramer","year":"1997","unstructured":"Kramer A, Behrens-Baumann W. Prophylactic use of topical anti-infectives in ophthalmology. Ophthalmologica. 1997;211 Suppl 1:68\u201376.","journal-title":"Ophthalmologica"},{"key":"1111_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF02560508","volume":"27","author":"P Rudolph","year":"1999","unstructured":"Rudolph P, Fritze F, Reimer K, Klebingat KJ, Kramer A. Efficacy and local tolerability of povidone iodine (Betaisodona) and octenidine hydrochloride solution (Octenisept) for the antiseptic preparation of the orificium urethrae. Infection. 1999;27:108\u201313.","journal-title":"Infection"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1111-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1111-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T15:44:40Z","timestamp":1498232680000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1111-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1111-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]},"article-number":"375"}}